PDS Biotechnology Corp - Common (PDSB) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common
Symbol
PDSB on Nasdaq
Shares outstanding
49,594,356
Price per share
$0.91
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
7,880,200
Total reported value
$6,066,657
% of total 13F portfolios
0%
Share change
+2,278,952
Value change
+$1,624,175
Number of holders
42
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 31 Dec 2025, 42 institutional investors reported holding 7,880,200 shares of PDS Biotechnology Corp - Common (PDSB). This represents 16% of the company’s total 49,594,356 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of PDS Biotechnology Corp - Common (PDSB) together control 16% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARMISTICE CAPITAL, LLC 5.7% 2,834,506 0.05% $2,182,003
VANGUARD GROUP INC 3.9% 1,950,946 +2.6% 0% $1,502,228
BlackRock, Inc. 1.1% 522,211 +0.91% 0% $401,998
GEODE CAPITAL MANAGEMENT, LLC 1% 520,398 +8% 0% $400,666
UBS Group AG 0.51% 251,705 +26% 0% $193,812
BLAIR WILLIAM & CO/IL 0.5% 250,000 0% 0% $192,450
COMMONWEALTH EQUITY SERVICES, LLC 0.4% 196,797 +117% 0% $151,490
Squarepoint Ops LLC 0.39% 192,556 -34% 0% $148,230
INSPIRION WEALTH ADVISORS, LLC 0.36% 180,495 -48% 0.02% $138,945
RENAISSANCE TECHNOLOGIES LLC 0.36% 176,700 -36% 0% $136,024
NORTHERN TRUST CORP 0.29% 143,873 +27% 0% $110,753
STATE STREET CORP 0.27% 133,333 0% 0% $102,640
Iron Gate Global Advisors LLC 0.15% 75,016 0% 0.01% $57,747
Bank of New York Mellon Corp 0.14% 69,311 +137% 0% $53,356
Tempus Wealth Planning, LLC 0.12% 61,800 +29% 0.01% $47,574
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.08% 38,566 -59% 0% $29,688
XTX Topco Ltd 0.07% 34,218 +74% 0% $26,341
Virtu Financial LLC 0.06% 32,099 0% $25,000
ACT CAPITAL MANAGEMENT, LLC 0.06% 30,000 0% 0.02% $23,094
Rockefeller Capital Management L.P. 0.05% 25,664 -26% 0% $19,756
SIMPLEX TRADING, LLC 0.04% 19,106 +54% 0% $14,711
StoneX Group Inc. 0.03% 16,000 0% $12,317
FIRST MANHATTAN CO. LLC. 0.03% 15,000 0% 0% $11,547
Federation des caisses Desjardins du Quebec 0.03% 14,800 -21% 0% $11,396
Ground Swell Capital, LLC 0.03% 14,703 0.02% $11,318

Institutional Holders of PDS Biotechnology Corp - Common (PDSB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 7,880,200 $6,066,657 +$1,624,175 $0.77 42
2025 Q3 5,620,337 $6,638,921 -$1,895,965 $1.01 47
2025 Q2 7,451,352 $9,901,943 -$1,043,791 $1.33 55
2025 Q1 8,226,452 $9,789,276 +$4,484,828 $1.19 46
2024 Q4 4,239,917 $6,914,602 -$572,034 $1.63 51
2024 Q3 4,325,988 $16,519,540 -$3,544,953 $3.82 56
2024 Q2 5,489,394 $16,083,121 -$6,957,012 $2.93 73
2024 Q1 7,611,671 $30,140,536 -$4,107,493 $3.96 69
2023 Q4 8,335,087 $41,487,859 +$2,355,421 $4.97 74
2023 Q3 7,861,668 $39,699,832 -$403,816 $5.05 78
2023 Q2 7,931,948 $39,898,006 -$317,214 $5.03 80
2023 Q1 7,611,967 $46,811,436 +$1,184,438 $6.15 66
2022 Q4 6,820,799 $90,031,703 +$24,029,740 $13.20 63
2022 Q3 5,178,399 $15,378,000 -$458,535 $2.97 42
2022 Q2 5,251,472 $19,171,000 -$3,835,298 $3.65 46
2022 Q1 5,851,637 $36,220,000 -$1,228,374 $6.19 49
2021 Q4 5,916,212 $47,919,000 -$12,229,786 $8.10 63
2021 Q3 6,752,518 $100,597,635 +$11,330,602 $14.90 58
2021 Q2 5,941,843 $74,429,183 +$40,638,979 $12.55 41
2021 Q1 3,145,310 $14,311,158 +$1,348,464 $4.55 29
2020 Q4 3,132,654 $6,703,955 -$487,455 $2.14 25
2020 Q3 3,298,108 $7,682,631 +$3,730,298 $2.33 27
2020 Q2 1,702,221 $3,419,000 +$619,479 $2.01 18
2020 Q1 1,628,998 $1,184,000 +$761,576 $0.72 19
2019 Q4 539,706 $1,429,005 +$70,841 $2.65 15
2019 Q3 509,321 $1,716,054 +$122,431 $3.37 16
2019 Q2 460,755 $2,759,096 +$1,030,776 $5.99 16
2019 Q1 287,260 $2,124,000 +$2,124,000 $7.39 13